Sponsored by
This study evaluated a new MRI technique called delta T1 (difference between pre- and post-contrast T1-weighted images) to measure extent of resection and residual tumor volume. The technique provides an objective way to routinely assess surgical outcomes for glioblastoma, and delta T1 residual tumor volume of greater or less than 5 cm3 could be a potential metric in predicting patient survival.